These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. Münz C; Bickham KL; Subklewe M; Tsang ML; Chahroudi A; Kurilla MG; Zhang D; O'Donnell M; Steinman RM J Exp Med; 2000 May; 191(10):1649-60. PubMed ID: 10811859 [TBL] [Abstract][Full Text] [Related]
3. CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis. Wilson AD; Redchenko I; Williams NA; Morgan AJ Int Immunol; 1998 Aug; 10(8):1149-57. PubMed ID: 9723701 [TBL] [Abstract][Full Text] [Related]
4. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells. Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells. Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K Cancer Sci; 2008 Aug; 99(8):1633-42. PubMed ID: 18754877 [TBL] [Abstract][Full Text] [Related]
9. CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells. Long HM; Zuo J; Leese AM; Gudgeon NH; Jia H; Taylor GS; Rickinson AB Blood; 2009 Jul; 114(4):807-15. PubMed ID: 19443664 [TBL] [Abstract][Full Text] [Related]
10. Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1. Landais E; Saulquin X; Scotet E; Trautmann L; Peyrat MA; Yates JL; Kwok WW; Bonneville M; Houssaint E Blood; 2004 Feb; 103(4):1408-16. PubMed ID: 14563644 [TBL] [Abstract][Full Text] [Related]
11. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Gurer C; Strowig T; Brilot F; Pack M; Trumpfheller C; Arrey F; Park CG; Steinman RM; Münz C Blood; 2008 Aug; 112(4):1231-9. PubMed ID: 18519810 [TBL] [Abstract][Full Text] [Related]
12. Cytokine production and cytolytic mechanism of CD4(+) cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures. Sun Q; Burton RL; Lucas KG Blood; 2002 May; 99(9):3302-9. PubMed ID: 11964297 [TBL] [Abstract][Full Text] [Related]
13. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes. Traidl C; Sebastiani S; Albanesi C; Merk HF; Puddu P; Girolomoni G; Cavani A J Immunol; 2000 Sep; 165(6):3058-64. PubMed ID: 10975816 [TBL] [Abstract][Full Text] [Related]
14. Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells. Khanolkar A; Yagita H; Cannon MJ Virology; 2001 Aug; 287(1):79-88. PubMed ID: 11504544 [TBL] [Abstract][Full Text] [Related]
15. Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma. Taylor GS; Haigh TA; Gudgeon NH; Phelps RJ; Lee SP; Steven NM; Rickinson AB J Virol; 2004 Jan; 78(2):768-78. PubMed ID: 14694109 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells. Mautner J; Pich D; Nimmerjahn F; Milosevic S; Adhikary D; Christoph H; Witter K; Bornkamm GW; Hammerschmidt W; Behrends U Eur J Immunol; 2004 Sep; 34(9):2500-9. PubMed ID: 15307182 [TBL] [Abstract][Full Text] [Related]
17. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670 [TBL] [Abstract][Full Text] [Related]
18. MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response. Long HM; Chagoury OL; Leese AM; Ryan GB; James E; Morton LT; Abbott RJ; Sabbah S; Kwok W; Rickinson AB J Exp Med; 2013 May; 210(5):933-49. PubMed ID: 23569328 [TBL] [Abstract][Full Text] [Related]
19. Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders. Jones K; Nourse JP; Morrison L; Nguyen-Van D; Moss DJ; Burrows SR; Gandhi MK Blood; 2010 Sep; 116(13):2245-52. PubMed ID: 20562330 [TBL] [Abstract][Full Text] [Related]
20. Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity. Gudgeon NH; Taylor GS; Long HM; Haigh TA; Rickinson AB J Virol; 2005 May; 79(9):5477-88. PubMed ID: 15827162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]